This work is licensed under a Creative Commons Attribution 4.0 International License.
SEQ ID NO: 446 of Patent CN110785183A
General Information
DRACP ID DRACP06729
Peptide Name SEQ ID NO: 446 of Patent CN110785183A
Sequence VTAQVVGTERY
Sequence Length 11
UniProt ID Not available
PubChem CID Not available
Origin Synthetic
Type Synthetic peptide
Classification
Cancer targeted peptides Immunotherapeutic peptides
Activity Information
Hemolytic Activity Not available
Normal (non-cancerous) Cytotoxicity Not available
Target HLA-A*01
Affinity Not available
Mechanism Not available
Nature Anticancer
Structure Information
Helicity Not available
Linear/Cyclic Linear
Disulfide/Other Bond Not available
N-terminal Modification Free
C-terminal Modification Free
Other Modification None
Chiral L
Physicochemical Information
Formula C53H87N15O18
Absent amino acids CDFHIKLMNPSW
Common amino acids V
Mass 140091
Pl 6.4
Basic residues 1
Acidic residues 1
Hydrophobic residues 4
Net charge 0
Boman Index -1768
Hydrophobicity -1.82
Aliphatic Index 88.18
Half Life
Mammalian: 100 hour
Yeast: >20 hour
E.coli: >10 hour
Extinction Coefficient cystines 1490
Absorbance 280nm 149
Polar residues 4
Amino acid distribution
Literature Information
Literature 1
Pubmed ID Not available
Title Not available
Doi Not available
Year Not available
Patent
Patent ID CN110785183A
Patent Title Novel Peptides and Combination of Peptides for Use in Immunotherapy Against Lung Cancer, Including Nsclc, Sclc and Other Cancers
Other Iinformation Not available
Other Published ID Not available
This work is licensed under a Creative Commons Attribution 4.0 International License.